Anita Moon-Grady

MD FACC

Pediatric cardiologist
Director, Fetal Cardiovascular Program

About me

Dr. Anita Moon-Grady, director of the UCSF Fetal Cardiovascular Program, is a pediatric cardiologist who specializes in neonatal and perinatal medicine. She has expertise in pediatric and fetal echocardiography (heart ultrasound).

In research, Moon-Grady is interested in diastolic dysfunction (a problem with the relaxation phase of a heartbeat) and fetal cardiovascular assessment. Her studies include looking at noninvasive imaging modalities for investigating normal and abnormal cardiac function in patients with congenital heart disease.

Moon-Grady earned her medical degree from Stanford University School of Medicine. At University of California, Davis, she completed a residency in pediatrics and a fellowship in neonatology; at UCSF, she completed a fellowship in pediatric cardiology.

Moon-Grady has received many honors, including a deans' award for research at Stanford University, an outstanding hospital staff educator award and the Eli Gold Prize from the pediatrics department of UC Davis Medical Center, and an award for excellence in neonatology. She is a fellow of the American College of Cardiology and the American Academy of Pediatrics, and a member of the American Society of Echocardiography, Society of Pediatric Echocardiography and American Medical Association.

  • Education

    Stanford University School of Medicine, MD, 1993

  • Residencies

    UC Davis, Pediatrics, 1996

  • Fellowships

    UC Davis, Neonatology, 1999

    UCSF, Pediatric Cardiology, 2002

  • Academic Title

    Professor

Fetal Treatment Center

Betty Irene Moore Women's Hospital

1855 Fourth St., Second Floor, Room A-2432
San Francisco, CA 94158

Cardiology at Greenbrae

1100 S. Eliseo Dr., Suite 1
Greenbrae, CA 94904

Selected research

Decorative Caduceus

FAST Therapy Trial of Fetal Tachyarrhythmia

Recruiting

Decorative Caduceus

Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome

The primary outcome variable is fetal mitral valve and left ventricular growth due to successful balloon dilation, as determined by serial echocardiographic measurements

Recruiting

Share